Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Luis F. Budar-Fernández"'
Autor:
Vladimir Barrera Villanueva, Daniel Alejandro Barrera Amorós, Eira Ingrid Castillo Echeverria, Luis F. Budar-Fernández, Omar Israel Salas Nolasco, Luis A. Juncos, Lilia Rizo-Topete
Publikováno v:
Frontiers in Nephrology, Vol 3 (2023)
Severe liver failure is common in Low-and-Medium Income Countries (LMIC) and is associated with a high morbidity, mortality and represents an important burden to the healthcare system. In its most severe state, liver failure is a medical emergency, t
Externí odkaz:
https://doaj.org/article/175e3814ea404775b703ae615804d0b6
Autor:
Gustavo Martínez-Mier, Yamilli Rivera-Sanchez, Luis A. Jiménez-López, Carlos A. Allende-Castellanos, Edgar Guadalupe Aguilar-Sandoval, Maritza De la Paz-Román, Marco T Méndez-López, Luis F Budar-Fernández, Daniel A. Barrera-Amoros, Pedro I. Moreno-Ley, Ernesto Soto-Miranda, Mónica Martínez-Maldonado
Publikováno v:
Transplantation Proceedings. 53:1005-1009
Context Thymoglobulin is used effectively as induction agent in kidney transplantation but the optimal dose is not well established. Objective Demonstrate that low-dose thymoglobulin (3 mg/kg) has similar efficacy and safety compared to basiliximab i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cfa098a53b1de5ff7b7fc89e00cc4ec6
https://doi.org/10.1016/j.transproceed.2020.01.054
https://doi.org/10.1016/j.transproceed.2020.01.054
Autor:
Gustavo Martínez-Mier, Andrea Nachón-Acosta, Félix Guillermo Márquez-Celedonio, Luis Roberto Reyes-Constantino, Yamilli Rivera-Sanchez, Ángela Domínguez-Rodríguez, Pedro I. Moreno-Ley, Mónica Martínez-Maldonado, Luis F Budar-Fernández
Publikováno v:
Revista Mexicana de Trasplantes. 10:64-70
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::532f135535039c0678f8b7b76c5f2ba5
https://doi.org/10.35366/101413
https://doi.org/10.35366/101413
Autor:
Luis Vicente Vazquez-Crespo, Fausto Angeles-Hernández, Luis F Budar-Fernández, Luis A. Jiménez-López, Gustavo Martínez-Mier, Marco T Méndez-López, Einar Eduardo Fuentes-Zamudio, Pedro I. Moreno-Ley, Maritza De la Paz-Román, Carlos A. Allende-Castellanos, Julio Cesar Viñas-Dozal, Elias Bonilla-Casas
Publikováno v:
Transplantation Proceedings. 52:1140-1142
Pretransplant anti-HLA antibodies are a risk factor for graft rejection and loss, and its percentage estimate is known as panel-reactive antibody (PRA). Our objective was to evaluate the influence of PRA on the survival of renal grafts from living do
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6314c00ae5178c45f1d0c87451b72435
https://doi.org/10.1016/j.transproceed.2020.01.060
https://doi.org/10.1016/j.transproceed.2020.01.060
Autor:
Luis F Budar-Fernández, Gustavo Martínez-Mier, Lucia Vega-Rojano, Ernesto Soto-Miranda, Marco T Méndez-López, Carlos G Rizo-Velazquez, Pedro I. Moreno-Ley
Publikováno v:
Experimental and Clinical Transplantation. 17:170-176
OBJECTIVES Kidney transplant is the optimal treatment for children with end-stage renal disease. Multiple factors affect patient and graft survival. We assessed determinants of long-term patient/graft survival in our center by a retrospective review
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6568c5478b1a470fc1b4efe3d34d7d22
https://doi.org/10.6002/ect.2017.0265
https://doi.org/10.6002/ect.2017.0265
Autor:
Maritza De la Paz-Román, Gustavo Martínez-Mier, Luis A. Jiménez-López, Elias Bonilla-Casas, Einar Eduardo Fuentes-Zamudio, Fausto Angeles-Hernández, Carlos A. Allende-Castellanos, Julio Cesar Viñas-Dozal, Pedro I. Moreno-Ley, Luis Vicente Vazquez-Crespo, Marco T Méndez-López, Luis F Budar-Fernández
Publikováno v:
Transplantation proceedings. 52(4)
The Living Kidney Donor Profile Index (LKDPI) was recently created. This model predicts recipient risk of graft loss after living donor transplant. Herein, we applied the LDKPI to our population to analyze its performance.A retrospective analysis of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14dae0f6df10dc740063c8e8c6bd2a35
https://pubmed.ncbi.nlm.nih.gov/32197867
https://pubmed.ncbi.nlm.nih.gov/32197867
Autor:
Gustavo Martínez-Mier, Mauricio Salazar-Pérez, Carlos A. Allende-Castellanos, Melissa Oryana Gonzalez-Carrera, Luis F Budar-Fernández, Julio Cesar Viñas-Dozal, Maritza De la Paz-Román, Elias Bonilla-Casas, Einar Eduardo Fuentes-Zamudio, Luis A. Jiménez-López, Helena Gabriela Vega-Quesada, Pedro I. Moreno-Ley, Marco T Méndez-López
Publikováno v:
Transplantation proceedings. 52(4)
Background In Mexico during 2018, 15,072 patients were waiting for a deceased donor kidney transplant, and 969 deceased donor kidney transplants were performed. There is no annual data report of the waiting list activity in Mexico. Herein, we analyze
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59b5b2ca7420cb0886f72140b40aaa30
https://pubmed.ncbi.nlm.nih.gov/32173589
https://pubmed.ncbi.nlm.nih.gov/32173589
Autor:
Ernesto Soto-Miranda, D. Avila y Falfan, Gustavo Martínez-Mier, Luis F Budar-Fernández, A. Uscanga-Montesano, A. Gomez-Diaz, L.J. Mateu-Rivera, María Fernanda Trujillo-Martínez
Publikováno v:
Transplantation Proceedings. 48:596-599
Background Induction therapy is used to reduce the incidence of graft rejection and delayed graft function. Thymoglobulin is the most used inductor agent in deceased donor kidney transplantation due to its lower rejection and delayed graft function r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d51601d75ac215bd7de138884c80f30
https://doi.org/10.1016/j.transproceed.2016.02.018
https://doi.org/10.1016/j.transproceed.2016.02.018
Autor:
Gustavo Martínez-Mier, Luis F Budar-Fernández, Sandro F Ávila-Pardo, María Fernanda Trujillo-Martínez, A. Uscanga-Montesano, L.J. Mateu-Rivera, Marco T Méndez-López, Ernesto Soto-Miranda, D. Avila y Falfan
Publikováno v:
Transplantation proceedings. 48(2)
Background Induction therapy reduces the frequency of acute rejection and delayed graft function in renal transplantation. Basiliximab and Thymoglobulin are most commonly used agents for induction. Methods A retrospective study of two transplant cent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::043f49c282148088bcf515771b90471a
https://pubmed.ncbi.nlm.nih.gov/27110011
https://pubmed.ncbi.nlm.nih.gov/27110011
Publikováno v:
Clinical Transplantation. 24:467-473
Martinez-Mier G, Avila-Pardo SF, Mendez-Lopez MT, Budar-Fernandez LF. Long-term results after conversion from calcineurin inhibitors to sirolimus in renal transplant patients. Clin Transplant 2010: 24: 467–473. © 2009 John Wiley & Sons A/S. Abstra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0dd290281fe5cb32d0e0f0ef69e13d4f
https://doi.org/10.1111/j.1399-0012.2009.01082.x
https://doi.org/10.1111/j.1399-0012.2009.01082.x